Financial results - FARMAROSIB SRL

Financial Summary - Farmarosib Srl
Unique identification code: 32908551
Registration number: J32/252/2014
Nace: 4646
Sales - Ron
1.999.406
Net Profit - Ron
183.110
Employees
3
Open Account
Company Farmarosib Srl with Fiscal Code 32908551 recorded a turnover of 2024 of 1.999.406, with a net profit of 183.110 and having an average number of employees of 3. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Farmarosib Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 27.306 29.982 148.217 559.279 543.541 1.419.806 1.898.685 1.614.089 1.999.406
Total Income - EUR 50 28.290 30.175 148.531 561.414 544.803 1.423.915 1.926.404 1.627.810 2.017.061
Total Expenses - EUR 18.359 56.619 55.818 160.125 506.493 483.024 1.187.403 1.653.792 1.401.295 1.801.054
Gross Profit/Loss - EUR -18.308 -28.329 -25.643 -11.594 54.921 61.778 236.512 272.612 226.515 216.008
Net Profit/Loss - EUR -18.308 -28.616 -25.943 -13.076 49.328 56.484 216.269 235.457 195.709 183.110
Employees 0 2 2 0 0 2 2 3 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 24.6%, from 1.614.089 euro in the year 2023, to 1.999.406 euro in 2024. The Net Profit decreased by -11.506 euro, from 195.709 euro in 2023, to 183.110 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Farmarosib Srl

Rating financiar

Financial Rating -
FARMAROSIB SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Farmarosib Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Farmarosib Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Farmarosib Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Farmarosib Srl - CUI 32908551

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 91.854 85.957 79.897 86.114 80.385 75.078 70.761 65.941 63.676 357.548
Current Assets 7.953 13.453 5.364 75.377 224.607 280.496 669.142 628.934 793.484 932.478
Inventories 0 7.402 0 4.785 0 36.298 63.180 86.892 109.512 72.436
Receivables 1.756 1.062 1.683 57.185 165.639 230.523 451.950 188.661 179.334 605.540
Cash 6.198 4.989 3.681 13.406 58.968 13.675 154.012 353.381 504.638 254.501
Shareholders Funds -21.083 -49.484 -74.589 -86.297 -35.297 21.857 237.641 372.447 567.027 445.417
Social Capital 225 223 219 215 211 207 202 203 202 201
Debts 120.890 148.894 159.851 247.787 340.288 333.717 502.868 322.428 293.833 848.550
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 932.478 euro in 2024 which includes Inventories of 72.436 euro, Receivables of 605.540 euro and cash availability of 254.501 euro.
The company's Equity was valued at 445.417 euro, while total Liabilities amounted to 848.550 euro. Equity decreased by -118.440 euro, from 567.027 euro in 2023, to 445.417 in 2024.

Risk Reports Prices

Reviews - Farmarosib Srl

Comments - Farmarosib Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.